Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study

Digestive and Liver Disease · Published 2026-08-01 · DOI 10.1016/j.dld.2026.07.013

Free full text

Authors (7)

Yupeng Li, Yiming Mu, Fengxue Li, Jiandong Zhang, Jingxin Zhang, Lili Qiao, Yamin Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, Y., Mu, Y., Li, F., et al. (2026). Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.07.013

Related articles